The SARS-CoV-2 S protein and ACE2 binding assay is used to measure the direct binding of potential therapeutics to the S protein receptor-binding domain or ACE2 to determine the kinetics of the interaction or to measure whether the test molecule(s) disrupt the S protein /ACE2 interaction.
